Table 3. Parathyroid surgery details outcomes by group.
| Parameter | Group A, 2001–2007 (n = 16 patients) | Group B, 2008–2014 (n = 24 patients) | P value |
|---|---|---|---|
| Operation performed | .74 | ||
| MIP | 11 (69%) | 14 (58.3%) | |
| Bilateral exploration | 5 (31%) | 10 (41.7%) | |
| Etiology | .59 | ||
| Hyperplasia | 5 (31.3%) | 8 (33.3%) | |
| Adenoma | 11 (68.8%) | 16 (66.7%) | |
| Transient complications | .67 | ||
| Hoarseness | 0 (0%) | 0 (0%) | |
| Hypocalcemia | 3 (18.8%) | 3 (12.5%) | |
| Permanent complications | 1.00 | ||
| Hoarseness | 0 (0%) | 0 (0%) | |
| Hypocalcemia | 0 (0%) | 1 (4.3%) | |
| Wound complications | 1.00 | ||
| Hematoma | 0 (0%) | 0 (0%) | |
| Infection | 0 (0%) | 0 (0%) | |
| Cure at 6-month follow-up | 16 (100%) | 24 (100%) | 1.00 |
| Recurrence | 2 (12.5%) | 1 (4.2%) | .55 |
| Mean follow-up time (mo) | 28.4 ± 7.1 | 8.3 ± 1.7 | - |
Results represented as n (%).